Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Boehringer Mannheim describes antiplatelet agents

Dec. 18, 1997

Phase II trial of Vasoflux begins in acute MI

Dec. 17, 1997

Cytoprotective effects of TTC-909 demonstrated in SHR-SP

Dec. 15, 1997

Integrilin to be reviewed by FDA advisory panel

Dec. 11, 1997

New indication for Neutralase revealed

Dec. 11, 1997

Yamanouchi describes SAR leading to YM-60828, a potent and selective factor Xa inhibitor

Dec. 11, 1997

Novel antithrombotic agent developed at Otsuka

Dec. 11, 1997

3-Dimensional Pharmaceuticals discloses new serine protease inhibitors

Dec. 11, 1997

Potent, orally active gpIIb/IIIa receptor antagonist for once-daily administration

Dec. 2, 1997

Toyama's antiplatelet agent progresses to clinical studies

Nov. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 30, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026